MAPT and Alzheimer disease: By collecting NFTs that accumulate in the brains of AD patients and comparing their aggregate shapes and fiber morphologies, it is conceivable that more accurate subtype classification and personalized treatment based on the phosphorylation profile of tau and the morphology of aggregates within the patient’s brain could be achieved as future therapeutic targets for AD.